5-Isoquinolinesulfonamide, N-[2-[[(2E)-3-(4-bromophenyl)-2-methyl-2-propen-1-yl]amino]ethyl]- manufacturers
- ETB067
-
- $2500.00
-
2026-05-11
- CAS:1000995-79-8
- Purity:
- Supply Ability: 10g
|
| | 5-Isoquinolinesulfonamide, N-[2-[[(2E)-3-(4-bromophenyl)-2-methyl-2-propen-1-yl]amino]ethyl]- Basic information |
| | 5-Isoquinolinesulfonamide, N-[2-[[(2E)-3-(4-bromophenyl)-2-methyl-2-propen-1-yl]amino]ethyl]- Chemical Properties |
| | 5-Isoquinolinesulfonamide, N-[2-[[(2E)-3-(4-bromophenyl)-2-methyl-2-propen-1-yl]amino]ethyl]- Usage And Synthesis |
| Description | ETB067 is an H-89 analog. It acts as a PKA and AKT1 inhibitor with specificity on no longer inhibiting CAMK2B and neither affecting viability of mice nor causing any detectable tissue damage at the dose given. | | Uses | ETB067 is an active compound. | | References | [1] Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1 |
| | 5-Isoquinolinesulfonamide, N-[2-[[(2E)-3-(4-bromophenyl)-2-methyl-2-propen-1-yl]amino]ethyl]- Preparation Products And Raw materials |
|